Shareholders Foundation, Inc.

Derma Sciences Inc (DSCI) Shareholder News: Lawsuit Against Buyout by LifeSciences Holdings Corporation

A lawsuit was filed for investors in shares of Derma Sciences Inc (NASDAQ:DSCI) in connection with the proposed takeover and NASDAQ:DSCI stockholders should contact the Shareholders Foundation.


San Diego, CA -- (SBWIRE) -- 02/08/2017 -- The Shareholders Foundation announces that an investor who currently holds shares of Derma Sciences Inc (NASDAQ:DSCI), filed a lawsuit against the buyout of Derma Sciences Inc. by LifeSciences Holdings Corporation.

Investors who purchased shares of Derma Sciences Inc (NASDAQ:DSCI) and currently hold any of those NASDAQ:DSCI shares have certain options and should contact the Shareholders Foundation at or call 858-779-1554.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:DSCI stockholders by agreeing to sell Derma Sciences Inc too cheaply via an unfair process to Integra LifeSciences Holdings Corporation.

On January 10, 2017, Derma Sciences Inc (NASDAQ:DSCI) announced that it has signed an agreement whereby Derma Sciences will be acquired by Integra LifeSciences Holdings Corporation(Nasdaq: IART) for $7.00 per share of common stock in cash, or a total of approximately $204 million, and $32.00 per share for its outstanding shares of Series A Convertible Preferred Stock and $48.00 per share for its Series B Convertible Preferred Stock, reflecting the stated value of such preferred stock in each case.

However, plaintiff claims that the proposed consideration NASDAQ:DSCI shareholders will receive is grossly inadequate and undervalues Derma Sciences Inc. Indeed, at least one analyst has set the high target price for NASDAQ:DSCI shares at $8.50 per share. Derma Sciences Inc reported that its annual Total Revenue rose from $83.75 million in 2014 to $84.47 million in 2015. Shares of Derma Sciences Inc (NASDAQ:DSCI) reached in 2014 as high as $15.21 per share. In addition, the plaintiff alleges that the process is also unfair NASDAQ:DSCI stockholders.

On February 7, 2017, NASDAQ:DSCI shares closed at $7.00 per share

Those who are current investors in Derma Sciences Inc shares have certain options and should contact the Shareholders Foundation.

Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739